Determinación de la asociación entre Chlamydia trachomatis y Neisseria gonorrhoeae, en muestras de orina mediante técnicas de biología molecular

Determine the association Between Chlamydia Trachomatis and Neisseriae Gonorrhoeaethrough molecular biology techniques in urine samples

En el presente estudio se evaluó la asociación entre Chlamydia trachomatis (CT) y Neisseriae gonorrhoeae (NG), utilizando la técnica de COBAS AMPLICOR CT/NG Molecular System, en muestras de orina de 355 mujeres con un promedio de edad de 23.9 años; 20 muestras fueron positivas para CT, informándose una prevalencia de de 5.63%. Aunque estudios epidemiológicos han reportado relación entre la infección por Chlamydia trachomatis y las causadas por otros microorganismos como Neisseriae gonorrhoeae; en este estudio no se encontró asociación. Factores como el tipo de muestra y la presencia de inhibidores en la orina disminuyen la sensibilidad en la detección de Neisseriae gonorrhoeae.

1. Todar K. The pathogenic Neisseria. University of Wisconsin- Madison Department of Bacteriology; 2002.
2. Merz AJ. Interactions of pathogenic Neisseria with epithelial cell membranes. Annu rev cell dev biol 2000; (16): 423-57.
3. Kanoh Y. The infections by Chlamydia trachomatis and Neisseria gonorrhoeae Rinsho Byori 2002; 123 (Suppl Nov):57-61.
4. Wiesenfeld HC. Bacterial vaginosis is a strong predictor of Chlamydia trachomatis and Neisseria gonorrhoeae infection. Clin Infecto Dis 2003; 36(5): 663-8.
5. Knox J. Evaluation of self-colected samples in contrast to practitioner-collected samples for detection of Chlamydia
6. trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis PCR among Women living in remote areas. Sex transm dis 2002; 29(11): 647.
7. Koumans EH. Comparison of methodos for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using
8. commercially available nucleic acid amplification test and liquid pap smear medium. Journal of clinical microbiology
9. ; 41(4):1507-11.
10. Bachmann LH, Prevalence and factors associated with gonorrhoea and chamydial infection in at-risk females presenting to an urban emergency department. Sex Transm dis 2003; 30(4): 335-9.
11. Castillo MC. Purification and characterization of lactamase from Neisseria gonorrhoeae from clinical samples Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs and male urethral swabs. Revista latinoamericana de microbiologia 2001; 43(2):70-5.
12. Birch NC. Evaluation of urine specimen integrity in a public health STD screening program. Am J Pathol 2003;
13. (4):516-21.
14. Ministerio de salud pública. Informe epidemiológico Nacional INS: 2001; Nov 30; 6(22).
15. Carroll K. Evaluation of the ABBOTT LCx ligase chain reaction assay for detection of Chlamydia trachomatics and
16. Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted diseases clinic population. Journal of clinical microbiology 1998; 36(6):1630-3.
17. Farrell D. Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16S rRNA PCR. Journal of clinical microbiology 1999; 37(2): 386-90.
18. Hardick J. Surveillance of Chlamydia trachomatis and Neisseria gonorrhoeae infections in women in detection in
19. Baltimore, Maryland. Sex Transm dis 2003; 30(1): 64-70.
20. Taffa N. Prevalence of gonococcal and chlamydial infections and sexual risk behaviour among youth in Addis Adaba, Ethiopia. Sex transm dis 2002; 29(12): 828-33.
21. Palmer HM. Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria
22. gonorrhoeae Journal of Clinical Mycrobiology 2003; 41(2): 835-7.
23. Schachter J. Which test is best for Chlamydia? Curr Opin Infect Dis 1999; 12;41-5.
24. Van der pol B, et al. Multicenter evaluation of the BD ProbeTec ET system for detection of Chlamydia trachomatis
25. and Neisseria gonorrhoeae in urine specimens, female endocervical swabs and male urethral swabs. Journal of clinical microbiology 2001; 39(3): 1008-16.
26. Newman SB, et al. Female prisioners preferences of collection methods for testing for Chlamydia trachomatis and Neisseria gonorrhoeae infection. Sex Transm dis 2003; 30(4): 306-9.
27. Van doornum GJ. Comparison between the LCx probe system and the COBAS AMPLICOR system for detection of
28. Chlamydia trachomatis and Neisseria gonorrhoeae. Infections in patients attending a clinic for treatment of
29. sexually transmitted diseases in amsterdam the Netherlands. Journal of clinical microbiology 2001; 39(3): 829-35.
30. Makepeace B, et al. Interactions of Neisseria gonorrhoeae with Mature Human Macrophage Opacity Proteins Influence Production of Proinflammatory Cytokines. Infection and immunity 2001; 69(3): 1909-13.
31. Massari P. The role of porins in neisserial pathogenesis and immunity. Trends Microbiol 2003; 11(2):87-93.
32. Mazzone M, et al. Whole-genome organization and functional properties of miniature DNA insertion sequences conserved in pathogenic Neisseria. Gene 2001; 278(1-2): 211-22.
33. Mcknew DL, et al. Porin variation among clinical isolates of Neisseria gonorrhoeae over a 10 year period, as determinated by variable region typing. J Infection disease 2003; 187(8):
34. -22.
35. Rahman M, et al. Etiology of sexually transmitted infections among street based female sex workers in Dhaka Bangladesh. Journal of microbiology 2000; 38(3): 1244-6.
36. Pujol C, et al. Do pathogenic Neisseria need several ways to the host cell cytoskeleton? Microbes and infection 2000; 2(7) 821-7.
37. -------------------------------------------------------------------------------
38. DOI: http://dx.doi.org/10.22490/24629448.4